Evaluation of Pulpotomy Using Two Different Agents in Mature Anterior Teeth With Pulpitis
Launched by AIN SHAMS UNIVERSITY · Jun 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective two different materials, NeoPutty® and Biodentine™, are for treating certain dental issues in children and teenagers. Specifically, the study will focus on young patients aged 9 to 14 who have mature front teeth that are experiencing pulpitis, which is inflammation of the dental pulp often caused by deep cavities or trauma. The goal is to see how these materials compare to traditional root canal treatment over a period of 12 months.
To participate, children must have healthy front teeth with severe cavities or injuries that have exposed the pulp, but they should not have any signs of infection or other serious dental problems. Parents and guardians should also be aware that the trial is not yet recruiting participants, meaning it hasn't started enrolling children yet. If eligible, participants will receive treatment and have follow-up visits at 3, 6, 9, and 12 months to assess the success of the procedures. This study could help improve treatment options for young patients with dental pulp issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children and adolescents of both sexes aged between 9 and 14 years old.
- • Vital mature permanent anterior teeth with deep caries lesions that approach the pulp with signs of pulpitis and respond positive to cold pulp testing.
- • Vital mature permanent anterior teeth with pulpal exposure that occurred during caries excavation.
- • Patients presented immediately after suffering recent trauma (at the same day) to mature anterior teeth that had resulted in a crown fracture with pulp exposure.
- Exclusion Criteria:
- • Teeth with signs of infection such as swelling, sinus tract or pathological mobility or excessive mobility.
- • Teeth with excessive bleeding from amputated radicular stumps
- • Teeth showing radiographic evidence of pathologic root resorption, periapical pathology and calcifications in the canals.
- • Lack of patient/parent compliance and cooperation.
- • Children who are physically or mentally disabled or having any medical condition that will complicate the treatment.
- • Patients allergic to any medicaments used.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nagwa Khattab, BDS,MSc, MD
Study Director
Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported